Bismuth-Cyclized Cell-Penetrating Peptides
Intracellular delivery of biological cargos, which would yield new research tools and novel therapeutics, remains an active area of research. A convenient and potentially general approach involves the conjugation of a cell-penetrating peptide to a cargo of interest. However, linear CPPs lack sufficient cytosolic entry efficiency and metabolic stability, while previous backbone cyclized CPPs have several drawbacks including the necessity for chemical synthesis and posttranslational conjugation to peptide/protein cargos and epimerization during cyclization. We report here a new class of bismuth cyclized CPPs with excellent cytosolic entry efficiencies, proteolytic stability, and potential compatibility with genetic encoding and recombinant production.
Authors
- Dehua Pei (ORCID: https://orcid.org/0000-0002-2057-6934)
- Jeremy L. Ritchey
- Davis Ballard
- Lindsi Filippi
Institutions
- The Ohio State University (US)
Publication Details
- Journal
- Molecular Pharmaceutics
- Published
- 2024-09-03
- DOI
- https://doi.org/10.1021/acs.molpharmaceut.4c00688
- Citations
- 11
- Primary Topic
- RNA Interference and Gene Delivery
- Type
- article
- Field-Weighted Citation Impact
- 2.57
Funders
- National Institutes of Health